Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Ovid Therapeutics (OVID): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Outperform
11 analysts
Options Flow (P/C)
—
Avg Consensus PT
$5
+93.9%
Highest Price Target
$9
+267.3%
Lowest Price Target
$1
-51.0%
Short Interest
12.4%
Rising — Bearish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 6, 2026 | Guggenheim | Delma Caiati— | +185.7% | $7 | Initiate | Buy |
| Oct 5, 2026 | Guggenheim | Delma Caiati— | +185.7% | $7 | Initiate | Buy |